...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020

Average time to get a drug from pre clinical to market average 12 years, I think RVX is  close to 15  years,   It takes a  long long time,  Interesting article  on how hard it is to get a drug to market  5 in 5000,  Apabetalone with its BTD is pretty damn close, with the right BP partner i think RVX we'll get that NDA , At this juncture i think they know what will  work and what won't with the next BETONMACE2 trial

There you go SF,  these junior biotech investments can take 15 years or more , dead money for most of them over that time but the pot of gold  at the end of the rainbow, give it a rest or sell out 

https://www.medicinenet.com/script/main/art.asp?articlekey=9877

 

 

 

Share
New Message
Please login to post a reply